The New Weight Loss Drug That Could Dethrone Ozempic

The Trend: If it seems like the buzz around Ozempic has quieted, that’s because it has — in favor of a new, potentially more powerful weight loss drug. Retatrutide, an experimental medication from Eli Lilly, is being hailed as the next big thing in obesity treatment. In a mid-stage clinical trial, participants lost nearly 30% of their body weight over 68 weeks. It’s so effective that some trial participants have dropped out, reportedly worried they were losing too much weight. “Gymbros” are getting it off-label on sites disguised as fitness coaching programs.

What People Are Saying: The stuff works, no doubt. One doctor tells GQ that it’s “the most effective means ever created through science to reduce the storage of fat.” Researchers say the drug’s triple-hormone action may explain the dramatic fat loss, and obesity specialists are cautiously optimistic. Other doctors express concern about the drugs exacerbating eating disorders and body dysmorphia. 

What to Know: Retatrutide is still in Phase 3 trials, meaning it could be years before regulators review it for approval. There are open questions about long-term safety, muscle retention, and what happens when patients stop taking it. For now, experts stress that while retatrutide looks promising, it’s not available outside research settings and shouldn’t be taken off-label.